5/20/2024 Correction: We will only be adding 168 medications. The infusion site of care rules will not apply to Qalsody, J Code 1304 or Spinraza, J Code 2326.
Starting July 15, 2024, the Infusion Site of Service policy for our commercial members for both EmblemHealth and ConnectiCare is being updated to remove age restrictions and to add 170 more medications. This means that pediatric patients up to the age of 21 will also be required, when medically appropriate, to receive infusions in a non-hospital setting. See announcement (EmblemHealth | ConnectiCare) for additional impacted medications.
